RLAY

Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming drug discovery through its innovative protein motion platform. The company specializes in targeting allosteric sites to develop novel therapeutics for patients with specific genetic mutations, particularly in oncology and other areas with significant unmet medical needs. With a robust pipeline supported by strategic collaborations, Relay Therapeutics aims to advance treatment precision and improve patient outcomes, positioning itself as a leader in the evolving landscape of personalized medicine.